PlainRecalls
FDA Drug Moderate Class II Terminated

Aripiprazole Tablets, USP, 15 mg, 30 tablets per unit dose carton, Rx Only, Manufactured by: Apotex, Inc, Toronto, Ontario Canada M9L 1T9, Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152 USA, NDC 0904-6512-04

Reported: December 9, 2020 Initiated: November 18, 2020 #D-0114-2021

Product Description

Aripiprazole Tablets, USP, 15 mg, 30 tablets per unit dose carton, Rx Only, Manufactured by: Apotex, Inc, Toronto, Ontario Canada M9L 1T9, Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152 USA, NDC 0904-6512-04

Reason for Recall

Failed Dissolution Specifications: Out of specification for dissolution.

Details

Recalling Firm
The Harvard Drug Group
Units Affected
841 cartons
Distribution
Nationwide
Location
Livonia, MI

Frequently Asked Questions

What product was recalled?
Aripiprazole Tablets, USP, 15 mg, 30 tablets per unit dose carton, Rx Only, Manufactured by: Apotex, Inc, Toronto, Ontario Canada M9L 1T9, Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152 USA, NDC 0904-6512-04. Recalled by The Harvard Drug Group. Units affected: 841 cartons.
Why was this product recalled?
Failed Dissolution Specifications: Out of specification for dissolution.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 9, 2020. Severity: Moderate. Recall number: D-0114-2021.